ENANTA PHARMACEUTICALS, INC Liability for Uncertainty in Income Taxes, Noncurrent
ENANTA PHARMACEUTICALS, INC (ENTA) had Liability for Uncertainty in Income Taxes, Noncurrent of $87.00 thousand as of 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:LiabilityForUncertainTaxPositionsNoncurrent · last filed 2022-08-08
- 2022-06-30: Liability for Uncertainty in Income Taxes, Noncurrent $87.00K.
- 2022-03-31: Liability for Uncertainty in Income Taxes, Noncurrent $530.00K.
- 2021-12-31: Liability for Uncertainty in Income Taxes, Noncurrent $520.00K.
- 2021-09-30: Liability for Uncertainty in Income Taxes, Noncurrent $558.00K.
| Period end | Liability for Uncertainty in Income Taxes, Noncurrent |
|---|---|
| 2022-06-30 | $87.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $530.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | $520.00K 10-Q · filed 2022-02-10 |
| 2021-09-30 | $558.00K 10-Q · filed 2022-08-08 |
| 2021-06-30 | $529.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $686.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $675.00K 10-Q · filed 2021-02-09 |
| 2020-09-30 | $788.00K 10-K · filed 2021-11-24 |
| 2020-06-30 | $776.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $764.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.68M 10-Q · filed 2020-02-10 |
| 2019-09-30 | $1.75M 10-K · filed 2020-11-25 |
| 2019-06-30 | $1.86M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $1.92M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $1.95M 10-Q · filed 2019-02-08 |
| 2018-09-30 | $1.79M 10-K · filed 2019-11-27 |
| 2018-06-30 | $1.49M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.44M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.19M 10-Q · filed 2018-02-09 |
| 2017-09-30 | $1.18M 10-K · filed 2018-11-29 |
| 2017-06-30 | $1.11M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.07M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.06M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $745.00K 10-K · filed 2017-12-11 |
| 2016-06-30 | $668.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $510.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $498.00K 10-Q · filed 2016-02-09 |
| 2015-09-30 | $448.00K 10-K · filed 2016-12-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |